United Services Automobile Association Boosted Asml Holding Nv (ASML) Position; Group One Trading LP Has Trimmed By $1.88 Million Its Biomarin Pharmaceutical (BMRN) Stake

December 6, 2017 - By Kurt Siggers

United Services Automobile Association increased Asml Holding Nv (ASML) stake by 139.08% reported in 2017Q2 SEC filing. United Services Automobile Association acquired 45,500 shares as Asml Holding Nv

(ASML)’s stock rose 6.28%. The United Services Automobile Association holds 78,214 shares with $10.19M value, up from 32,714 last quarter. Asml Holding Nv now has $72.43B valuation. The stock decreased 0.36% or $0.62 during the last trading session, reaching $169.88. About 304,473 shares traded. ASML Holding N.V. (NASDAQ:ASML) has risen 44.52% since December 6, 2016 and is uptrending. It has outperformed by 27.82% the S&P500.

Group One Trading Lp decreased Biomarin Pharmaceutical Inc (BMRN) stake by 88.63% reported in 2017Q2 SEC filing. Group One Trading Lp sold 20,913 shares as Biomarin Pharmaceutical Inc (BMRN)’s stock declined 0.71%. The Group One Trading Lp holds 2,683 shares with $244,000 value, down from 23,596 last quarter. Biomarin Pharmaceutical Inc now has $14.17B valuation. The stock decreased 0.11% or $0.09 during the last trading session, reaching $80.67. About 184,600 shares traded. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since December 6, 2016 and is uptrending. It has underperformed by 11.41% the S&P500.

Since June 7, 2017, it had 0 insider purchases, and 2 sales for $1.69 million activity. FUCHS HENRY J also sold $1.35 million worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares. Ajer Jeffrey Robert sold 1,004 shares worth $89,968. Shares for $337,500 were sold by LAWLIS V BRYAN.

Among 27 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 19 have Buy rating, 0 Sell and 8 Hold. Therefore 70% are positive. BioMarin Pharmaceutical had 74 analyst reports since August 5, 2015 according to SRatingsIntel. Raymond James initiated the stock with “Outperform” rating in Tuesday, September 1 report. The rating was maintained by William Blair on Wednesday, August 5 with “Buy”. The firm has “Outperform” rating by RBC Capital Markets given on Friday, February 26. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has “Overweight” rating given on Thursday, September 14 by PiperJaffray. Piper Jaffray downgraded the shares of BMRN in report on Monday, November 7 to “Neutral” rating. The company was maintained on Friday, October 6 by Morgan Stanley. The firm has “Overweight” rating given on Friday, August 5 by Piper Jaffray. Gabelli initiated BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Thursday, December 8 with “Buy” rating. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) earned “Buy” rating by Jefferies on Wednesday, May 31. The stock has “Outperform” rating by Credit Suisse on Wednesday, January 20.

Group One Trading Lp increased Canadian Solar Inc (Put) stake by 234,300 shares to 335,300 valued at $5.34 million in 2017Q2. It also upped Harley Davidson Inc (Call) stake by 20,700 shares and now owns 48,000 shares. Us Bancorp Del (Put) was raised too.

Analysts await BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to report earnings on February, 22. They expect $-0.25 earnings per share, up 32.43% or $0.12 from last year’s $-0.37 per share. After $-0.07 actual earnings per share reported by BioMarin Pharmaceutical Inc. for the previous quarter, Wall Street now forecasts 257.14% negative EPS growth.

Investors sentiment increased to 1.26 in 2017 Q2. Its up 0.06, from 1.2 in 2017Q1. It increased, as 23 investors sold BMRN shares while 124 reduced holdings. 51 funds opened positions while 134 raised stakes. 168.09 million shares or 1.78% more from 165.15 million shares in 2017Q1 were reported. Canada Pension Plan Board holds 0.03% or 138,075 shares in its portfolio. United Kingdom-based Gulf Retail Bank (Uk) Limited has invested 0.07% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). 43,500 are owned by Weiss Multi. Frontier Cap Co Limited invested 0.54% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Eventide Asset Management holds 0.42% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) or 75,000 shares. 306,353 are held by Eagle Asset Mgmt. Century Companies accumulated 373,679 shares or 0.04% of the stock. Tci Wealth Advisors reported 0% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Tower Cap (Trc) reported 0% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Portfolio Solutions Limited Liability Company holds 0% or 29 shares. Comgest Sas holds 24,000 shares or 0.05% of its portfolio. Swiss Bank stated it has 631,600 shares or 0.07% of all its holdings. Baker Bros Advsrs LP owns 4.69% invested in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 5.91 million shares. 6,251 are owned by Argent Tru. Columbus Circle Investors accumulated 100,780 shares or 0.15% of the stock.

United Services Automobile Association decreased Delphi Automotive Plc (NYSE:DLPH) stake by 154,450 shares to 448,147 valued at $39.28 million in 2017Q2. It also reduced United Therapeutics Corp (NASDAQ:UTHR) stake by 60,447 shares and now owns 16,556 shares. Osi Systems Inc (NASDAQ:OSIS) was reduced too.

Among 16 analysts covering ASML Holding NV (NASDAQ:ASML), 10 have Buy rating, 0 Sell and 6 Hold. Therefore 63% are positive. ASML Holding NV had 32 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained ASML Holding N.V. (NASDAQ:ASML) rating on Monday, October 2. RBC Capital Markets has “Hold” rating and $155.0 target. The firm earned “Buy” rating on Wednesday, June 14 by Citigroup. Bank of America upgraded the shares of ASML in report on Monday, December 19 to “Buy” rating. The stock of ASML Holding N.V. (NASDAQ:ASML) earned “Neutral” rating by Credit Suisse on Thursday, April 21. The firm has “Hold” rating by Deutsche Bank given on Friday, January 22. The firm has “Hold” rating by RBC Capital Markets given on Monday, June 5. As per Tuesday, April 19, the company rating was maintained by Summit Research. B. Riley & Co maintained the stock with “Hold” rating in Thursday, July 20 report. Bryan Garnier & Cie upgraded ASML Holding N.V. (NASDAQ:ASML) on Thursday, January 21 to “Buy” rating. B. Riley & Co maintained ASML Holding N.V. (NASDAQ:ASML) on Thursday, October 19 with “Neutral” rating.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>